Clinical Trial Update: Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating metformin with dietary restriction to prevent age-related morbid events in people with metabolic syndrome; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Metabolic Syndrome | Phase 3 | Status: COMPLETED